PROF公司概览
盘中时间采用ET。市场数据可能有所延迟。
公司概况
公司网站Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland. Its flagship product, the TULSA-PRO system, is specifically designed for use with magnetic resonance imaging (MRI) scanners within hospital settings and other treatment centers. Additionally, Profound Medical offers Sonalleve, a therapeutic platform that addresses uterine fibroids – including through non-invasive methods – and provides palliative relief for pain linked to bone metastases. The company's primary operations are headquartered in Mississauga, Canada.
- 行业
- Medical - Devices
- 部门
- Healthcare
- 总部
- CA
- 首席执行官
- Arun Swarup Menawat
- 上市以来
- 2019年10月29日
- 雇员
- 162
市场位置
日内区间
当前US$5.68
52周区间
当前US$5.68
- 开盘价
- US$5.99
- 前收盘价
- US$6.08
- 成交量
- 32.49万
- 3.12× 平均值
- 平均成交量
- 10.41万
- 日均成交量
- 市值
- 2.06亿 USD
- 贝塔
- 0.53
- 市场参考 1
- 50天平均值
- US$6.6251
- 低于平均水平-14.27%
- 200天平均值
- US$6.8218
- 低于平均水平-16.74%
